Repligen Corp.
NASDAQ:RGEN 4:00:00 PM EDT
| Market Cap (Intraday) | 7.79B |
| Current PE | N/A |
| Forward PE | 96.56 |
| 2yr Forward PE | 73.57 |
| 10-Day MA | $142.64 |
| 50-Day MA | $149.58 |
| 200-Day MA | $163.47 |
Repligen Corp. Stock, NASDAQ:RGEN
41 Seyon Street, Building 1, Suite 100, Waltham, Massachusetts 02453
United States of America
Phone: +1.781.250.0111
Number of Employees: 1783
Description
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.